Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-response of gabapentin enacarbil in DPN pain
NCT00643760Phase 2Completed
- Sponsor
- XenoPort, Inc.
- Start
- Mar 2008
- Primary completion
- Feb 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gabapentin enacarbil in diabetic peripheral neuropathy (DPN), sponsored by XenoPort, Inc.. Started Mar 2008; status: completed.
02
Drugs
gabapentin enacarbil
03
Conditions
diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT00643760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00643760.